Latest Updates & News
FDA Approves Talvey for Multiple Myeloma on August 9, 2023
What is Talvey prescribed for? Talvey is prescribed to treat adults with relapsed or refractory multiple myeloma who have received at least four prior therapies. What is the name of the drug and what does it do? The name of the drug is Talvey, pronounced tal vay, (generic name: talquetamab-tgvs). It is a prescription medication approved to treat adults...
FDA Approves XDEMVY for Treating Demodex Blepharitis on July 25, 2023
What is XDEMVY prescribed for? XDEMVY is prescribed to treat a parasitic infection of the eye (Demodex blepharitis) that can especially affect the eyelids. What is the name of the drug and what does it do? XDEMVY, pronounced X-DEM-VEE, (generic name: lotilaner) is a prescription medication approved for the treatment of Demodex blepharitis, a...
FDA Approves Leqembi for Alzheimer’s Disease on on July 6, 2023
What is Leqembi prescribed for? Leqembi is prescribed to treat Alzheimer’s disease for people in the early stages of the disease. What is the name of the drug and what does it do? The U.S. Food and Drug Administration has approved Leqembi (generic name: lecanemab-irmb), pronounced “leh-kem’-bee,” for the treatment of Alzheimer's disease. ...
FDA Approves Dupixent for Children Suffering from Eosinophilic Esophagitis on January 2024
What is Dupixent prescribed for? DUPIXENT (generic name: dupilumab), pronounced DU-pix-ent is prescribed for children aged 1 year and older to treat eosinophilic esophagitis (EoE), a chronic inflammatory condition of the esophagus. EoE is caused by a buildup of eosinophils, a type of white blood cell, which leads to damage and inflammation in the esophagus. This can...
FDA Approves Amtagvi for Advanced Skin Cancer on February 16, 2024
What is Amtagvi prescribed for? Amtagvi is prescribed to treat adult patients with unresectable or metastatic melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor with or without a MEK inhibitor. What is the name of the drug and what does it do? The newly approved drug is called Amtagvi...
FDA Expands Approval of Elevidys Gene Therapy for Duchenne Muscular Dystrophy: June 2023
What is Elevidys prescribed for? To treat Duchenne muscular dystrophy (DMD) in patients who are 4 years of age and older and have a confirmed mutation in the DMD gene. What is the name of the drug and what does it do? Elevidys (generic name: delandistrogene moxeparvovec-rokl), pronounced "el-eh-vid-iss," is a special treatment approved by the U.S....